Skip to main content

Peer Review reports

From: Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk

Original Submission
18 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
14 Mar 2022 Reviewed Reviewer Report
9 Apr 2022 Reviewed Reviewer Report
18 Sep 2022 Author responded Author comments - Paul Albert
Resubmission - Version 4
18 Sep 2022 Submitted Manuscript version 4
24 Sep 2022 Author responded Author comments - Paul Albert
Resubmission - Version 5
24 Sep 2022 Submitted Manuscript version 5
27 Sep 2022 Author responded Author comments - Paul Albert
Resubmission - Version 6
27 Sep 2022 Submitted Manuscript version 6
10 Oct 2022 Reviewed Reviewer Report
25 Oct 2022 Reviewed Reviewer Report
5 Nov 2022 Author responded Author comments - Paul Albert
Resubmission - Version 7
5 Nov 2022 Submitted Manuscript version 7
15 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
21 Nov 2022 Editorially accepted
16 Dec 2022 Article published 10.1186/s12874-022-01798-0

You can find further information about peer review here.

Back to article page